UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001214
Receipt No. R000001477
Scientific Title Phase II study of Neoadjuvant Letrozole and Docetaxel for Postmenopausal, Endocrine-responsive and Anthracycline non-responsive Breast Cancer (JBCRG-05)
Date of disclosure of the study information 2008/06/27
Last modified on 2019/11/21 16:37:20

No. Disposal Last modified on Item of update
1 Insert 2008/06/27 15:34:49
2 Update 2008/12/16 14:33:01 Email1


3 Update 2009/08/21 11:15:50 Organization
Organization
Institute
Organization
Organization1
4 Update 2009/11/11 14:17:04 Recruitment status
5 Update 2011/06/27 15:35:54 Recruitment status
6 Update 2011/08/31 14:23:50 Post marketing survey by drug manufacture etc., specified by Japanese law.
Email1
7 Update 2012/05/13 23:12:44 Recruitment status
8 Update 2016/07/06 09:33:16 Email
Address
Address
TEL
Address
Address
TEL
Name of primary sponsor
Organization
Address1
Tel1
9 Update 2018/08/24 10:02:20 UMIN ID1
UMIN ID2
10 Update 2019/11/21 16:28:13 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Homepage URL
Organization
Institute
Organization
Organization1
Organization
Organization
Address
Address
Tel
Email
11 Update 2019/11/21 16:31:33 Date of IRB
12 Update 2019/11/21 16:37:20 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.